Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Ugeskr Laeger ; 179(31)2017 Jul 31.
Article in Danish | MEDLINE | ID: mdl-28869010

ABSTRACT

Intestinal tuberculosis is a rare diagnosis, which may often be mistaken for mb. Crohn or cancer. We present a case of a 57-year-old man, who was diagnosed with intestinal tuberculosis. Due to increased abdominal pain, a computed tomography was performed, revealing a growing sigmoidal tumour, and the biopsies taken showed an adenocarcinoma. Further histological tests revealed no spread of cancer, and the patient could receive curative surgery. While intestinal tuberculosis can appear similar to colon cancer, it may also as in this case be an intercurrent disease.


Subject(s)
Adenocarcinoma/complications , Sigmoid Neoplasms/complications , Tuberculosis, Gastrointestinal/complications , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Humans , Male , Middle Aged , Romania/ethnology , Sigmoid Neoplasms/pathology , Sigmoid Neoplasms/surgery , Tuberculosis, Gastrointestinal/therapy
2.
Ugeskr Laeger ; 173(39): 2425-6, 2011 Sep 26.
Article in Danish | MEDLINE | ID: mdl-21958489

ABSTRACT

A 91 year-old man was found to have diffuse large cell B-cell lymphoma (DLBCL), localized to the stomach. Because of his age, his only treatment was anti-Helicobacter pylori therapy. He achieved a complete remission, and six months after the initial presentation, there were no signs of recurrence. The recommended treatment of DLBCL is chemotherapy followed by involved-field irradiation. However, small prospective trials have shown high rates of complete remission after eradication of H. pylori alone and this treatment is an option in patients of advanced age or with severe co-morbidities.


Subject(s)
Helicobacter Infections/drug therapy , Helicobacter pylori , Lymphoma, Large B-Cell, Diffuse , Stomach Neoplasms , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Gastric Mucosa/pathology , Helicobacter Infections/complications , Humans , Lymphoma, Large B-Cell, Diffuse/complications , Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse/microbiology , Male , Neoplasm Regression, Spontaneous , Remission Induction , Stomach Neoplasms/complications , Stomach Neoplasms/drug therapy , Stomach Neoplasms/microbiology
3.
Neurourol Urodyn ; 25(2): 116-22, 2006.
Article in English | MEDLINE | ID: mdl-16402391

ABSTRACT

BACKGROUND AND AIMS: Prevalence of lower urinary tract symptoms (LUTS) in Parkinsons disease (PD) is reported as 27%-39% based on validated questionnaires which do not consider the degree of bother. To estimate the prevalence of LUTS in patients with PD, the severity of symptoms, the volume of postmicturitional urine, and to estimate differences compared to non-PD patients referred for urological evaluation. METHODS: One hundred seven patients with PD were evaluated using two sets of validated questionnaires (Dan-PSS and IPSS) about LUTS; postmicturitional residual urine was recorded, and compared to 61 patients without PD presenting at an urological clinic for examination. RESULTS: Bothersome LUTS measured using Dan-PSS scores correlated significantly with Hoehn and Yahr stage of disease (P = 0.02), but not with duration of disease or age. IPSS scores did not correlate to stage of disease, duration of disease or age. Two arbitrary cut-offs were applied, identifying patients with significant LUTS, Dan-PSS > 10 and IPSS > 10. There were no significant differences between the age or duration of disease of patients with and without significant LUTS. The most frequent symptom was nocturia (IPSS: 86%) followed by frequency (IPSS: 71%) and urgency (IPSS: 68%). The most frequently reported bothersome bladder symptom was urgency (Dan-PSS: 61%), followed by nocturia (Dan-PSS: 50%) and urge incontinence (Dan-PSS: 44%). The prevalence of bothersome frequency is low (Dan-PSS: 37%). The postmicturitional volumes (PMV) did not correlate to stage of disease, duration of disease or age, or to scores on questionnaires. Mean PMV was 34 ml. Seven patients (6%) with PD had a PMV larger then 100 ml. DISCUSSION: The prevalence of severe LUTS was similar with other studies, but the correlation between Dan-PSS and stage of disease, and not IPSS indicates that despite seeing no increase in frequency and severity of LUTS as PD progresses, patients find symptoms more bothersome. This may be due to progression in gait difficulties or a decreasing ability to separate and integrate sensory input, or both.


Subject(s)
Parkinson Disease/complications , Urinary Bladder Diseases/epidemiology , Urinary Bladder Diseases/etiology , Adult , Aged , Aged, 80 and over , Antiparkinson Agents/therapeutic use , Denmark/epidemiology , Female , Humans , Levodopa/therapeutic use , Male , Middle Aged , Prostatic Diseases/epidemiology , Regression Analysis , Surveys and Questionnaires , Urinary Bladder Diseases/physiopathology , Urodynamics/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...